Reduced natriuresis during weightlessness.
The kidney response to weightlessness was measured in one volunteer during a 1-week space mission. Shortly after entering microgravity and later during the mission, consecutive urine sampling periods were monitored, covering in total about 50% of the inflight time. Preflight references were a sequence of ground-based experiments, which evaluated body fluid metabolism with different degrees of standardization. Additional variables, such as circadian rhythms and cortisol-associated stress, were also monitored. In contrast to current hypotheses, the volunteer showed a pronounced reduction in natriuresis and diuresis during the entire space flight, despite a considerable weight loss. For the first time, the urinary excretion of the renal natriuretic peptide urodilatin was also measured. Both, during the preflight experiments and during weightlessness, close correlations between urodilatin excretion and sodium excretion were observed. However, the correlation between natriuresis and urodilatin excretion was considerably altered during weightlessness. We conclude that the loss of body weight during space flight is not related to an increased renal fluid loss and that urodilatin might counteract the decrease in renal excretion observed in weightlessness.
Drummer
C
C
Medizinische Klinik, Klinikum Innenstadt, Universität München.
Heer
M
M
Dressendörfer
R A
RA
Strasburger
C J
CJ
Gerzer
R
R
D009320:Atrial Natriuretic Factor / Q000652:urine; D001826:Body Fluids / Q000378:metabolism; D002940:Circadian Rhythm / Q000502:physiology; D004232:Diuretics / Q000652:urine; D006801:Humans; D008297:Male; D008991:Monitoring, Physiologic; D009318:Natriuresis / Q000502:physiology*; D010446:Peptide Fragments / Q000652:urine; D013026:Space Flight; D013312:Stress, Physiological / Q000378:metabolism; D014893:Weightlessness
D004232:Diuretics; D010446:Peptide Fragments; C056452:Ularitide; D009320:Atrial Natriuretic Factor